Literature DB >> 3754135

Purification and characterization of ascamycin-hydrolysing aminopeptidase from Xanthomonas citri.

H Osada, K Isono.   

Abstract

A nucleoside antibiotic, ascamycin (9-beta-[5'-0-(N-L-alanyl) sulphamoyl-D-ribofuranosyl]-2-chloroadenine), has a selective antibacterial activity against Xanthomonas species. When ascamycin was dealanylated, dealanylascamycin showed a broad antibacterial activity against various Gram-negative and Gram-positive bacteria. Xanthomonas citri is susceptible to ascamycin by virtue of the ascamycin-dealanylating enzyme on the cell surface [Osada & Isono (1985) Antimicrob. Agents Chemother. 27, 230-233]. The enzyme (Xc aminopeptidase) was purified from X. citri cells by successive DEAE-cellulose, chromatofocusing and Sephadex G-100 column chromatography to a homogeneous state. The purified enzyme exhibited a single band with an Mr of 38 000 in SDS/polyacrylamide-gel electrophoresis. Gel filtration on a calibrated column indicated a similar Mr value. The isoelectric point of the enzyme was 5.7. The enzyme catalysed the hydrolysis of the alanyl group of ascamycin and liberated alanine from the sulphamoyl nucleoside. The enzyme also catalysed the hydrolysis of L-proline beta-naphthylamide and L-alanine beta-naphthylamide. The optimal pH and temperature for enzyme activity were pH 7.5-8.0 and 35-40 degrees C respectively. The enzyme was inhibited by thiol-enzyme inhibitors (i.e. rho-chloromercuribenzoate and N-ethylmaleimide), but was not affected by various naturally occurring aminopeptidase inhibitors (i.e. amastatin, bestatin, pepstatin and leupeptin). Mn2+ and Mg2+ activated the enzyme, whereas Cu2+, Zn2+ and Cd2+ were inhibitory.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754135      PMCID: PMC1153047          DOI: 10.1042/bj2330459

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics.

Authors:  R Benveniste; J Davies
Journal:  FEBS Lett       Date:  1971-05-20       Impact factor: 4.124

2.  The purification of a bovine kidney enzyme which cleaves melanocyte-stimulating hormone-release inhibiting factor.

Authors:  M A Khilji; G S Bailey
Journal:  Biochim Biophys Acta       Date:  1978-11-10

Review 3.  Plasmid-determined resistance to antimicrobial agents.

Authors:  J Davies; D I Smith
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

6.  Ascamycin and dealanylascamycin, nucleoside antibiotics from Streptomyces sp.

Authors:  K Isono; M Uramoto; H Kusakabe; N Miyata; T Koyama; M Ubukata; S K Sethi; J A McCloskey
Journal:  J Antibiot (Tokyo)       Date:  1984-06       Impact factor: 2.649

7.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

8.  Mechanism of action and selective toxicity of ascamycin, a nucleoside antibiotic.

Authors:  H Osada; K Isono
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

9.  Mechanisms of gentamicin resistance in Staphylococcus aureus.

Authors:  J E Dowding
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

10.  Proline iminopeptidase from Bacillus megaterium: purification and characterization.

Authors:  T Yoshimoto; T Saeki; D Tsuru
Journal:  J Biochem       Date:  1983-02       Impact factor: 3.387

View more
  6 in total

1.  Isolation and characterization of the gene encoding an aminopeptidase involved in the selective toxicity of ascamycin toward Xanthomonas campestris pv. citri.

Authors:  T Sudo; K Shinohara; N Dohmae; K Takio; R Usami; K Horikoshi; H Osada
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

2.  Production, purification and characterization of intracellular alanylaminopeptidase of Pseudomonas sp.

Authors:  U Jankiewicz; W Bielawski
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

Review 3.  Discovery and applications of nucleoside antibiotics beyond polyoxin.

Authors:  Hiroyuki Osada
Journal:  J Antibiot (Tokyo)       Date:  2019-09-25       Impact factor: 2.649

4.  Characterization of biosynthetic genes of ascamycin/dealanylascamycin featuring a 5'-O-sulfonamide moiety in Streptomyces sp. JCM9888.

Authors:  Chunhua Zhao; Jianzhao Qi; Weixing Tao; Lei He; Wei Xu; Jason Chan; Zixin Deng
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

5.  Antimicrobial cyclic peptides for plant disease control.

Authors:  Dong Wan Lee; Beom Seok Kim
Journal:  Plant Pathol J       Date:  2015-03-31       Impact factor: 1.795

Review 6.  Biosynthesis of sulfonamide and sulfamate antibiotics in actinomycete.

Authors:  Takayoshi Awakawa; Lena Barra; Ikuro Abe
Journal:  J Ind Microbiol Biotechnol       Date:  2021-06-04       Impact factor: 4.258

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.